In an effort to eliminate nearly 40,000 new HIV infections in the U.S. each year, the U.S. Preventive Services Task Force recommended Truvada, which can reduce the risk of infection by 92% when taken daily, should be offered to more patients. High cost has been a barrier, and so far fewer than 10% of high-risk people take the medication.
from Kaiser Health News http://bit.ly/2Zof8KJ
June 12, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Tough to Tell COVID From Smoke Inhalation Symptoms — And Flu Season’s ComingThe patients walk into Dr. Melissa Marshall’s community clinics in Northern California with the telltale symptoms. They’re having trouble breathing. It may even hurt to inhale. They’ve got a cough, and the sore throat is defi… Read More
Es difícil decir si es COVID, síntomas por inhalar humo… o la gripe que ya llegaLos pacientes entran en las clínicas comunitarias de la doctora Melissa Marshall, en el norte de California, con síntomas reveladores. Tienen problemas para respirar, tos, y dolor de garganta. ¿Un caso claro de COVID-19? No t… Read More
Es difícil decir si es COVID, síntomas por inhalar humo… o la gripe que ya llegaLos pacientes entran en las clínicas comunitarias de la doctora Melissa Marshall, en el norte de California, con síntomas reveladores. Tienen problemas para respirar, tos, y dolor de garganta. ¿Un caso claro de COVID-19? No t… Read More
COVID Vaccine Trials Move at Warp Speed, But Recruiting Black Volunteers Takes TimeParticipation in clinical trials among Black people is low, according to Food and Drug Administration statistics. Still, including them in coronavirus vaccine trials has been a stated priority for the pharmaceutical companies… Read More
Lack of Antigen Test Reporting Leaves Country ‘Blind to the Pandemic’More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus, which has sickened more than 6 million Americans. The lapses leave officials and th… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment